These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

573 related items for PubMed ID: 28127997

  • 1. Investigational drug therapies for the treatment of gastroparesis.
    Sanger GJ, Pasricha PJ.
    Expert Opin Investig Drugs; 2017 Mar; 26(3):331-342. PubMed ID: 28127997
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. New developments in the treatment of gastroparesis and functional dyspepsia.
    Tack J, Camilleri M.
    Curr Opin Pharmacol; 2018 Dec; 43():111-117. PubMed ID: 30245474
    [Abstract] [Full Text] [Related]

  • 5. Relamorelin Reduces Vomiting Frequency and Severity and Accelerates Gastric Emptying in Adults With Diabetic Gastroparesis.
    Lembo A, Camilleri M, McCallum R, Sastre R, Breton C, Spence S, White J, Currie M, Gottesdiener K, Stoner E, RM-131-004 Trial Group.
    Gastroenterology; 2016 Jul; 151(1):87-96.e6. PubMed ID: 27055601
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Gastroparesis: separate entity or just a part of dyspepsia?
    Stanghellini V, Tack J.
    Gut; 2014 Dec; 63(12):1972-8. PubMed ID: 25260920
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Comparative effects of levosulpiride and cisapride on gastric emptying and symptoms in patients with functional dyspepsia and gastroparesis.
    Mansi C, Borro P, Giacomini M, Biagini R, Mele MR, Pandolfo N, Savarino V.
    Aliment Pharmacol Ther; 2000 May; 14(5):561-9. PubMed ID: 10792119
    [Abstract] [Full Text] [Related]

  • 11. Ghrelin and motilin receptors as drug targets for gastrointestinal disorders.
    Sanger GJ, Furness JB.
    Nat Rev Gastroenterol Hepatol; 2016 Jan; 13(1):38-48. PubMed ID: 26392067
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Influence of ghrelin on gastric emptying and meal-related symptoms in idiopathic gastroparesis.
    Tack J, Depoortere I, Bisschops R, Verbeke K, Janssens J, Peeters T.
    Aliment Pharmacol Ther; 2005 Nov 01; 22(9):847-53. PubMed ID: 16225494
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Malignant gastroparesis: pathogenesis and management of an underrecognized disorder.
    Donthireddy KR, Ailawadhi S, Nasser E, Schiff MD, Nwogu CE, Nava HR, Javle MM.
    J Support Oncol; 2007 Sep 01; 5(8):355-63. PubMed ID: 17944143
    [Abstract] [Full Text] [Related]

  • 19. Prokinetics in diabetic gastroparesis.
    Hejazi RA, McCallum RW, Sarosiek I.
    Curr Gastroenterol Rep; 2012 Aug 01; 14(4):297-305. PubMed ID: 22688694
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 29.